+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A pilot study of hydroxyurea treatment of severely affected children with sickle cell disease



A pilot study of hydroxyurea treatment of severely affected children with sickle cell disease



Pediatric Research 33(4 Part 2): 147A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029745982

Download citation: RISBibTeXText


Related references

Hydroxyurea treatment in severely affected sickle cell disease children. Beuzard, Y, Lubin, B, Rosa, J, INSERM Colloquium; Sickle cell disease and thalassaemias: New trends in therapy, Colloque INSERM; Sickle cell disease and thalassaemias: New trends in therapy 171-172, 1995

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 19(4): 313-318, 1997

Hydroxyurea therapy in severely affected children with sickle cell disease. Pediatric Research 35(4 Part 2): 163A, 1994

Hydroxyurea therapy in children severely affected with sickle cell disease. Journal Of Pediatrics. 128(6): 820-828, 1996

Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease. Hemoglobin 36(4): 323-332, 2012

Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes?. Pediatric Blood and Cancer 63(5): 844-847, 2016

Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study. Clinical Therapeutics 27(7): 1083-1088, 2005

A two-year pilot trial of hydroxyurea in very young children with sickle cell disease. Blood 94(10 Suppl. 1 Part 1): 644a, Nov 15, 1999

Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. Blood 91(12): 4472-4479, 1998

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatric Blood and Cancer 52(5): 609-615, 2008

A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease. Pediatric Blood and Cancer 61(6): 1068-1073, 2014

Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatric Blood and Cancer 59(2): 365-371, 2012

Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea. Sleep and Breathing 21(3): 697-701, 2017

Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric Blood and Cancer 62(11): 1956-1961, 2015

Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica 91(1): 125-128, 2006